Infinitum Health Secures Breakthrough Cancer & Viral Therapy Patent, Eyes Expansion

[As reported by Phoenix Business Journal, 9/1/2025]

Sept 1, 2025 - Infinitum Health, LLC, a biotechnology company dedicated to developing natural, evidence-based therapies, proudly announces the issuance of its groundbreaking U.S. Patent No. 12,364,725 for "Methods of Inhibiting Cancer Growth and Inhibiting Viral Infections."

This milestone validates 14 years of research, innovation, and dedication to addressing some of the world’s most pressing health challenges, including cancer and infectious diseases. The newly granted U.S. patent describes proprietary compositions that demonstrate statistically significant reduction in cancer cell viability across multiple cancer types, including glioblastoma, melanoma, prostate, lung, and leukemia. Additionally, preclinical studies conducted with academic and clinical partners confirmed the safety and efficacy of Infinitum Health’s formulations in reducing tumor viability on an additional 9 cancer cell lines, bringing the total to 13 different cancer types. In addition to the U.S. patent, Infinitum Health has an international patent application pending for its Methods of Relieving Pain. This pending intellectual property covers a novel natural composition that leverages plant-based extracts—such as Incarvillea sinensis, willow bark, feverfew, papain, and bromelain—to provide effective, non-addictive pain relief for both acute and chronic conditions, including migraines, arthritis, and post-surgical pain. Early clinical evidence suggests that this formula may represent a safer alternative to opioids and NSAIDs, a timely innovation given the ongoing opioid crisis. Together, these patents form the cornerstone of Infinitum Health’s growing intellectual property portfolio, which also includes multiple trademarks and a proprietary mathematical modeling platform for product development Company Vision and Market Strategy Founded by Kevin Engholdt, MS, MBA, Infinitum Health was created with the vision of becoming the world’s foremost biotechnology company focused on natural, integrative solutions to cancer, viruses, skin health, reproduction, and pain management. Its flagship consumer products—such as Infinimin® (a now patented immuno-supportive supplement), Infiniderm® (a natural anti-aging lotion with natural UV protection), ReLeaf™ (a patent-pending pain relief formulation), Ancient Cleanse™ Soap, and Dragon Roast™ Coffee—disrupt traditional healthcare and wellness categories with clinically informed, plant-based innovation. Infinitum Health also has a unique whiskey brand, Immortalis™, that is currently under development. The oncology, antiviral, and pain relief markets represent enormous opportunities, with global spending projected to surpass $200 billion in oncology therapeutics and $75 billion in antiviral treatments by 2027. Pain relief alone is a $113 billion global market, underscoring the urgent demand for effective, safer alternatives to addictive pharmaceuticals Next Steps: Investment and Acquisition Opportunities Infinitum Health’s immediate goals are to: Seek strategic investment – The company is currently pursuing a $15M Series A funding round to advance its IP portfolio, conduct Phase III clinical trials in oncology, viral infections, and pain management, and scale distribution

Pursue acquisition or strategic partnerships – Infinitum Health is open to collaboration with major pharmaceutical and consumer healthcare companies seeking to expand their portfolios with clinically validated, natural biotechnologies “Our patents are more than scientific achievements—they are a symbol of hope,” said Kevin Engholdt, Founder & CEO of Infinitum Health. “We are proving that safe, natural formulations can deliver real efficacy in treating cancer, viral infections, and chronic pain. This is the future of biotechnology—healthcare that is effective, efficient, and accessible.” About Infinitum Health Infinitum Health, LLC, based in Phoenix, Arizona, is a biotechnology company dedicated to developing innovative, natural therapies for cancer, viruses, pain relief, reproduction, and skin health. Leveraging a proprietary mathematical model, clinical research partnerships, and a growing IP portfolio, Infinitum Health seeks to transform consumer healthcare with safe, effective, and disruptive products. For more information, visit www.infinitumhealth.com Media Contact: Kevin Engholdt, MS, MBA Founder & CEO, Infinitum Health, LLC info@infinitumhealth.com (480) 371-6620

Patent(s) Below for Reference

Cancer and Viral Patent.

Download • 2.62MB

Pain Reliever Patent.

Download • 2.21MB